Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in Eastern Saudi Arabia

American Journal of Infection Control

Volumn 33, Issue 3, 2005, Pages 189-191

  Fawaz, Naglaa A ^a   Tamim, Hala ^b   Almawi, Wassim Y ^c  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; MALE; NONHUMAN; PREVALENCE; RISK FACTOR; SAUDI ARABIA; SCREENING; VIRUS TRANSMISSION; WESTERN BLOTTING;

EID: 15744386944     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2004.08.006     Document Type: Article

References (15)

1. M. Matsuoka Human T-cell leukemia virus type I and adult T-cell leukemia Oncogene 22 2003 5131 5140
2. J.R. Orland, J. Engstrom, J. Fridey, R.A. Sacher, J.W. Smith, and C. Nass Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study Neurology 61 2003 1588 1594
3. S.G. Sandler, C.T. Fang, and A.E. Williams Human T-cell lymhotropic virus type I and II in transfusion medicine Transfus Med Rev 5 1991 93 107
4. R. Cesaire, O. Bera, H. Maier, A. Lezin, J. Martial, and M. Ouka Seroindeterminate patterns and seroconversions to human T-lymphotropic virus type I positivity in blood donors from Martinique, French West Indies Transfusion 39 1999 1145 1149
5. A. Manns, R.J. Wilks, E.L. Murphy, G. Haynes, J.P. Figueroa, and M. Barnett A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion Int J Cancer 51 1992 886 891
6. R. Naman, S. Klayme, M. Naboulsi, J. Mokhbat, O. Jradi, and S. Ramia HTLV-I and HTLV-II infections in volunteer blood donors and high-risk groups in Lebanon J Infect 45 2002 29 31
7. M. Arif, and S. Ramia Seroprevalence of human T-lymphotropic virus type I (HTLV-I) in Saudi Arabia Ann Trop Med Parasitol 92 1998 305 309
8. H. Vrielink, and H.W. Reesink HTLV-I/II prevalence in different geographic locations Transfus Med Rev 18 2004 46 57
9. S. Al-Mufti, A. Voevodin, S. Ahmed, S. Al-Hamdan, and A.A. Al-Bisher Prevalence of human T-cell lymphotropic virus type I infection among volunteer blood donors in Kuwait J Acquir Immune Defic Syndr Hum Retrovirol 15 1997 88 90
10. H. Knox-Macaulay, R. McDonald, S. al-Busaidy, and N. Ali HTLV-I seroprevalence in the Sultanate of Oman Scand J Infect Dis 29 1997 217 218
11. M.M. El-Hazmi Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia Saudi Med J 25 2004 26 33
12. S.S. Bernvil, V. Andrews, and N. Coulter International forum: Saudi Arabia. Donor screening for HTLV-I in Saudi Arabia: is it cost effective? Transfus Sci 18 1997 45 47
13. K. Arisawa, T. Sobue, I. Yoshimi, M. Soda, S. Shirahama, and H. Doi Human T-lymphotropic virus type-I infection, survival and cancer risk in southwestern Japan: a prospective cohort study Cancer Causes Control 14 2003 889 896
14. K. Nakao, N. Ohba, M. Nakagawa, and M. Osame Clinical course of HTLV-I-associated uveitis Jpn J Opthalmol 43 1999 404 409
15. M. Shohat, D. Ben Amitai, B. Shohat, R. Mosberg, R. Narinski, and T. Klein Atopic dermatitis and HTLV-1-associated myelopathy: associated or coincidental disorders? Dermatology 199 1999 356 360